Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (16324)	10/4/2003 12:13:11 PM
From: Bluegreen	Respond to of 17367

George, the shout was for the attention BPI is getting. Now say that someone had a chronic deficiency of BPI and you wanted to protect them long term this MIGHT be a way. Also as you very well know BPI has been tweaked to rbpi21 for a reason. You DO you remember rbpi23 don't you??? I hope that you see were there MIGHT be a HUGE need for Neuprex in ACUTE life threatening gram neg infections IF given in a TIMELY manner just like the conventional antibiotic therapy. Remember the newborn issue? I really like the move towards using ANY type of BPI for PREVENTIVE, PROTECTIVE reasons!!!!!!!!! >>>>>>>>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12032259&dopt=Abstract >>>>>>>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12032258&dopt=Abstract